Heart Failure Clinical Trial
Official title:
Randomized Clinical Trial of Ivabradine to Reduce Heart Rate Prior to Coronary CT-angiography in Advanced Heart Failure: Comparison With β-Blocker
Verified date | April 2019 |
Source | Rajaie Cardiovascular Medical and Research Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this study is to compare the effects of Ivabradine and metoprolol to reduce heart rate prior to coronary CT angiography in patients with advanced heart failure.
Status | Recruiting |
Enrollment | 200 |
Est. completion date | December 2019 |
Est. primary completion date | December 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Sinus rhythm - Heart rate >60/min Exclusion Criteria: - Atrial fibrillation - Any contraindication for beta-blocker use |
Country | Name | City | State |
---|---|---|---|
Iran, Islamic Republic of | Ahmad Amin | Tehran |
Lead Sponsor | Collaborator |
---|---|
Rajaie Cardiovascular Medical and Research Center |
Iran, Islamic Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Heart rate | Changing heart rate during imaging study | 30 minutes before and after coronary CT angiography | |
Secondary | Dyspnea | Shortness of breath, or "dyspnea", is the most famous symptom of left ventricular failure. It typically appears during strenuous activities, and progresses to ordinary activities, less than ordinary activities and ultimately resting state. The severity is categorized as above (FC 1 to 4) | 30 minutes before and after coronary CT angiography and 6 months later | |
Secondary | Functional calss | Heart Failure severity has been classified according to New York Heart Association (NYHA) to: Class I: No limitation of physical activity. Ordinary physical activity does not cause symptoms of HF. Class II: Slight limitation of physical activity. Comfortable at rest, but ordinary physical activity results in symptoms of HF. Class III: Marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes symptoms of HF. Class IV: Unable to perform any physical activity without symptoms of HF, or symptoms of HF at rest. |
30 minutes before and after coronary CT angiography and 6 months later | |
Secondary | Blood pressure, systolic and diastolic | The amount of blood pressure measured by sphygmomanometer | 30 minutes before and after coronary CT angiography and 6 months later | |
Secondary | Sleep quality | The rate of disturbed sleep measured as better than before, Worse than before, and No change There are no standard classification for severity of this symptom. In our study, we measure this symptom as : Better than before (1) Worse than before (2) No change (0) |
Before CT angiography and 6 months later | |
Secondary | Appetite | The rate of changing in appetite level measured as better than before, Worse than before, and No change Loss of appetite is a common symptom of heart failure. There are no standard classification for severity of this symptom. In our study, we measure this symptom as : Better than before (1) Worse than before (2) No change (0) |
Before CT angiography and 6 months later | |
Secondary | Prolonged bradycardia | Persistence of Bradycardia more than 6 hours is called prolonged bradycardia. | 30 minutes before and after coronary CT angiography | |
Secondary | Hypotension | Systolic less than 80 mm Hg | 30 minutes before and after coronary CT angiography |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05196659 -
Collaborative Quality Improvement (C-QIP) Study
|
N/A | |
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Active, not recruiting |
NCT05896904 -
Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction
|
N/A | |
Completed |
NCT05077293 -
Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
|
||
Recruiting |
NCT05631275 -
The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
|
||
Enrolling by invitation |
NCT05564572 -
Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology
|
N/A | |
Enrolling by invitation |
NCT05009706 -
Self-care in Older Frail Persons With Heart Failure Intervention
|
N/A | |
Recruiting |
NCT04177199 -
What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
|
||
Terminated |
NCT03615469 -
Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY)
|
N/A | |
Recruiting |
NCT06340048 -
Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure
|
Phase 1/Phase 2 | |
Recruiting |
NCT05679713 -
Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
|
||
Completed |
NCT04254328 -
The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure
|
N/A | |
Completed |
NCT03549169 -
Decision Making for the Management the Symptoms in Adults of Heart Failure
|
N/A | |
Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
Enrolling by invitation |
NCT05538611 -
Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
|
||
Recruiting |
NCT04262830 -
Cancer Therapy Effects on the Heart
|
||
Completed |
NCT06026683 -
Conduction System Stimulation to Avoid Left Ventricle Dysfunction
|
N/A | |
Withdrawn |
NCT03091998 -
Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support
|
Phase 1 | |
Recruiting |
NCT05564689 -
Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy
|